key: cord-1005342-93srxbi5 authors: Patanè, L; Cadamuro, M; Massazza, G; Pirola, S; Stagnati, V; Comerio, C; Carnelli, M; Arosio, M; Callegaro, AP; Tebaldi, P; Rigoli, E; Gianatti, A; Morotti, D title: Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second trimester twin stillbirth in asymptomatic woman. Case report and review of the literature date: 2022-02-04 journal: Am J Obstet Gynecol MFM DOI: 10.1016/j.ajogmf.2022.100589 sha: d695cd6106b947dfbd33bd10fa542a981ac57bfb doc_id: 1005342 cord_uid: 93srxbi5 Data on the vertical transmission rate of COVID-19 in pregnancy are limited, while data reporting mother-fetal transmission in the second trimester of pregnancy are controversial. We described a case of second trimester twin stillbirth in a woman positive for SARS-CoV-2 in which, despite the absence of respiratory syndrome, placental and fetal markers of infection were detected. The patient developed a clinical chorioamnionitis and spontaneously delivered two stillborn infants. Placental histology and immunohistochemistry demonstrated SARS-CoV-2 infection mostly within the syncytiotrophoblast and the fetal autopsy showed development of interstitial pneumonia. Our findings demonstrate that, in utero vertical transmission is possible, also in asymptomatic SARS-CoV-2 pregnant women and that infection can lead to severe morbidity in the second trimester of pregnancy. Our findings demonstrate that, in utero vertical transmission is possible, also in asymptomatic SARS-CoV-2 pregnant women and that infection can lead to severe morbidity in the second trimester of pregnancy. There are few published reports regarding the possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vertical transmission during first or second trimester of pregnancy. This report describes a case of SARS-CoV-2 vertical transmission in a second trimester asymptomatic woman, with fetal SARS-CoV-2-related pneumonia leading to adverse fetal outcome . A 35 years old twin pregnant, SARS-CoV-2 PCR positive at nasopharyngeal swab , was admitted at 20 weeks for preterm premature rupture of membranes. The pregnancy was obtained by in vitro fertilization (IVF) and the patient received cervical cerclage at 16 weeks for cervical incompetence. At admission, the patient resulted asymptomatic, with negative chest x-ray and normal laboratory tests. The obstetric ultrasonography demonstrated a twin pregnancy, with normal growth of both fetuses and oligohydramnios of the first one. The patient firmly refused cerclage removal, and following a negative vaginal swabs, a prophylactic antibiotic therapy was started. At 21.4 weeks the patient's clinical conditions deteriorated; she became febrile with an increase of leukocyte count and PCR value. Due to the starting of a premature labor, cervical cerclage was removed and the patient delivered vaginally two stillborn fetuses. The postpartum course showed an immediate improvement of maternal conditions and the patient was discharged 3 days after with normal laboratory tests. In our case, the pregnant woman was asymptomatic but manifested serious adverse pregnancy outcome and placentas showed typical features already associated with SARS-CoV-2 vertical transmission (13) . The obstetric complications (premature rupture of membranes and cervical insufficiency) could have allowed SARS-CoV-2 entrance trough placenta to infect fetal tissue or, alternatively, SARS-CoV-2 infection together with inflammatory conditions could be the primum movens of the superimposed clinical chorioamnionitis. All data relating to the studies analyzed are summarized in table 2. This case report demonstrates that SARS-CoV-2 infection, in asymptomatic women, could be related with severe adverse fetal and maternal outcomes also in second trimester of pregnancy. These findings should to be taken into account when counselling pregnant women with SARS-CoV-2 infection in order to guarantee the optimal care. Incidence of SARS-CoV-2 vertical transmission: a meta-analysis. Arch Dis Child Fetal Neonatal Ed The Effects of COVID-19 on Placenta and Pregnancy: What Do We Know So Far? Diagnostics (Basel) The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis Chronic Histiocytic Intervillositis With Trophoblast Necrosis Is a Risk Factor Associated With Placental Infection From Coronavirus Disease 2019 (COVID-19) and Intrauterine Maternal-Fetal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Live-Born and Stillborn Infants Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infecting Pregnant Women and the Fetus COVID-19) Pandemic: It's Complicated Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection SARS-CoV-2 infection of the placenta Vertical transmission of SARS-CoV-2 infection and preterm birth Fetal and placental infection with SARS-CoV-2 in early pregnancy Protein expression of angiotensin-converting enzyme 2, a SARS-CoV-2-specific receptor, in fetal and placental tissues throughout gestation: new insight for perinatal 7 counseling Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.The Lancet Infectious Diseases Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2. Viruses SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; RT-PCR, reverse transcription-polymerase chain reaction FFPE, formalin-fixed paraffin-embedded IHC ab-NC, immunohistochemistry with antibody vs viral nucleocapsid protein; ISH Spike Protein, in situ hybridization with a RNA probe for the viral spike protein; IHC ab-ACE-2, immunohistochemistry with antibody vs angiotensin-converting enzyme 2 receptor